Reza Meshkani Selected Research

Palmitates

2/2021	Folic acid ameliorates palmitate-induced inflammation through decreasing homocysteine and inhibiting NF-κB pathway in HepG2 cells.
1/2020	Interplay between oxidative stress and autophagy function and its role in inflammatory cytokine expression induced by palmitate in skeletal muscle cells.
10/2018	Curcumin ameliorates palmitate-induced inflammation in skeletal muscle cells by regulating JNK/NF-kB pathway and ROS production.
1/2018	Palmitate-induced impairment of autophagy turnover leads to increased apoptosis and inflammation in peripheral blood mononuclear cells.
1/2017	Resveratrol Ameliorates Palmitate-Induced Inflammation in Skeletal Muscle Cells by Attenuating Oxidative Stress and JNK/NF-κB Pathway in a SIRT1-Independent Mechanism.
12/2014	Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
12/2013	Protein tyrosine phosphatase 1B inhibition ameliorates palmitate-induced mitochondrial dysfunction and apoptosis in skeletal muscle cells.
10/2012	Leukocyte antigen-related inhibition attenuates palmitate-induced insulin resistance in muscle cells.
5/2010	Palmitate and inflammatory state additively induce the expression of PTP1B in muscle cells.
3/2010	Protein tyrosine phosphatase-1B (PTP-1B) knockdown improves palmitate-induced insulin resistance in C2C12 skeletal muscle cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reza Meshkani Research Topics

Disease

18	Insulin Resistance 05/2022 - 09/2006
16	Type 2 Diabetes Mellitus (MODY) 05/2022 - 09/2007
14	Inflammation (Inflammations) 10/2021 - 09/2009
10	Obesity 01/2022 - 01/2016
9	Neoplasms (Cancer) 02/2021 - 12/2008
9	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2018
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2021 - 03/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2013
3	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2018
2	Hematologic Neoplasms (Hematological Malignancy) 06/2020 - 03/2020
2	Fatty Liver 01/2020 - 12/2008
2	Atherosclerosis 01/2018 - 09/2009
2	Metabolic Diseases (Metabolic Disease) 01/2018 - 01/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2017 - 01/2016
2	Dyslipidemias (Dyslipidemia) 12/2015 - 09/2015
2	Infections 02/2013 - 11/2007
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2022
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 09/2022
1	Weight Gain 10/2021
1	Diabetes Mellitus 06/2021
1	Chronic Disease (Chronic Diseases) 02/2021
1	Glucose Intolerance 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Sudden Infant Death (SID) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Carcinogenesis 01/2018

Drug/Important Bio-Agent (IBA)

13	Insulin (Novolin)FDA Link 10/2021 - 01/2007
10	PalmitatesIBA 02/2021 - 03/2010
10	ResveratrolIBA 03/2020 - 01/2016
9	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 09/2006
7	CytokinesIBA 01/2021 - 09/2009
5	LipidsIBA 01/2021 - 04/2008
5	Apolipoproteins B (ApoB)IBA 02/2019 - 04/2008
4	Metformin (Glucophage)FDA LinkGeneric 09/2022 - 01/2021
4	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 05/2022 - 09/2007
4	Blood Glucose (Blood Sugar)IBA 10/2021 - 01/2018
3	PolyphenolsIBA 01/2022 - 10/2018
3	HomocysteineIBA 02/2021 - 05/2013
3	Nicotinamide PhosphoribosyltransferaseIBA 07/2020 - 01/2018
3	Sirtuin 1IBA 07/2020 - 12/2013
3	AntigensIBA 06/2020 - 10/2012
3	C-Reactive ProteinIBA 05/2020 - 01/2018
3	Messenger RNA (mRNA)IBA 05/2020 - 01/2018
3	AdipokinesIBA 01/2018 - 09/2009
3	Proteins (Proteins, Gene)FDA Link 02/2017 - 03/2010
3	Lipoproteins (Lipoprotein)IBA 12/2015 - 12/2008
2	AntioxidantsIBA 10/2022 - 01/2020
2	GenisteinIBA 10/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2020 - 08/2016
2	JNK Mitogen-Activated Protein KinasesIBA 01/2020 - 01/2016
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2019 - 01/2018
2	AdiponectinIBA 02/2019 - 02/2017
2	NF-kappa B (NF-kB)IBA 12/2018 - 10/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 09/2009
2	Triglycerides (Triacylglycerol)IBA 01/2018 - 12/2015
2	Estrogen Receptor alphaIBA 01/2018 - 01/2012
2	LeptinIBA 01/2016 - 09/2009
2	ApolipoproteinsIBA 12/2008 - 04/2008
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 10/2022
1	biochanin AIBA 10/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2022
1	Insulin ReceptorIBA 05/2022
1	Circular RNAIBA 06/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2021
1	Linoleic Acid (Linoleate)IBA 02/2021
1	Conjugated Linoleic AcidsIBA 02/2021
1	Therapeutic UsesIBA 01/2021
1	Chlorogenic AcidIBA 01/2021
1	AMP-Activated Protein KinasesIBA 01/2021
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2021
1	NAD (NADH)IBA 07/2020
1	Chimeric Antigen ReceptorsIBA 06/2020
1	Monoclonal AntibodiesIBA 06/2020
1	MesothelinIBA 06/2020
1	Adenosine (Adenocard)FDA LinkGeneric 03/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	fibroblast growth factor 21IBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Oxytocin (Pitocin)FDA LinkGeneric 04/2019
1	Dopamine (Intropin)FDA LinkGeneric 04/2019
1	EsterasesIBA 02/2019
1	Aryldialkylphosphatase (Paraoxonase)IBA 02/2019
1	Histidine (L-Histidine)FDA Link 01/2019
1	Long Noncoding RNAIBA 10/2018
1	CurcuminIBA 10/2018
1	InterleukinsIBA 01/2018
1	LigandsIBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	CalciumIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	HDL CholesterolIBA 01/2018
1	CholesterolIBA 01/2018
1	Vitamin D-Binding ProteinIBA 10/2017
1	Streptozocin (Streptozotocin)FDA Link 05/2017
1	FructoseIBA 05/2017

Therapy/Procedure

7	Therapeutics 10/2021 - 01/2017
1	Endurance Training 01/2018